Darae's insight pays off — pain drug developer RudaCure selected for
Seoul-type private investissement-linked commercialisation technologique programme de soutien
RudaCure Inc. (PDG Yongho Kim), une entreprise spécialisée dans le développement de traitements pour les troubles sensoriels, recommended by Seoul-type TIPS operator Darae Strategic Commercialization Center Co., Ltd. (CEOs Bae Sun-gu and Kim Jeong-guk), was a annoncé le 30th as having been selected for the Seoul-type Private Investment-linked Technology Commercialization Support Program (Seoul-type TIPS).
The Seoul-type Private Investment-linked Technology Commercialization Support Program is a program in which Ville métropolitaine de Séoul and the Seoul Business Agency (sba) leverage the startup discovery and investissement capabilities of private operators to support prometteur technology startup companies. Grâce à cela selection, RudaCure a obtenu up to KRW 400 million in R&D funding over two years.
RudaCure prévoit d'utiliser the secured R&D funding to advance the development stage of its non narcotique chronic traitement de la douleur pipeline.
Bae Sun-gu, CEO of Darae Strategic Commercialization Center—RudaCure's investisseur and Seoul-type TIPS operator—a déclaré : "We recommended RudaCure sur la base de a high evaluation of the technological innovantness of its développement de médicaments for trouble sensoriel diseases," and a ajouté : "As a Seoul-type TIPS operator, we will more actively expand the infrastructure to match and support R&D funding without equity dilution for prometteur startups."
RudaCure le PDG Yongho Kim a déclaré : "S'appuyant sur this Seoul-type TIPS selection, we will focus on increasing company value by strengthening our non narcotique chronic traitement de la douleur alongside our main pipeline, the traitement de la sécheresse oculaire ROC001."
Pendant ce temps, Darae Strategic Commercialization Center is active as both a Ministère de SMEs and Startups TIPS operator and a Seoul-type TIPS operator, and plans to continuously expand strategic support for portefeuille companies with excellent technology.
전자신문: https://www.etnews.com/20231103000235